Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biotest (0N6Z) (DE:BIO)
:BIO
Holding DE:BIO?
Track your performance easily
BIO Stock Chart & Stats
Day’s Range― - ―
52-Week Range€40.60 - €43.00
Previous CloseN/A
Volume121.00
Average Volume (3M)85.00
Market Cap
€1.37B
Enterprise Value€2.24B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)24.0
Beta0.01
Next Earnings
Mar 28, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 08, 2024Dividend Yield0.1%
Share Statistics
EPS (TTM)1.73
Shares Outstanding19,785,727
10 Day Avg. Volume71
30 Day Avg. Volume85
Standard Deviation0.07
R-Squared0.05
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.27
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap1.64
Enterprise Value/Revenue4.33
Enterprise Value/Gross Profit17.90
Enterprise Value/Ebitda-199.59
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BIO FAQ
What was Biotest (0N6Z)’s price range in the past 12 months?
Biotest (0N6Z) lowest stock price was €40.60 and its highest was €43.00 in the past 12 months.
What is Biotest (0N6Z)’s market cap?
Biotest (0N6Z)’s market cap is €1.37B.
When is Biotest (0N6Z)’s upcoming earnings report date?
Biotest (0N6Z)’s upcoming earnings report date is Mar 28, 2025 which is in 68 days.
How were Biotest (0N6Z)’s earnings last quarter?
Biotest (0N6Z) released its earnings results on Nov 14, 2024. The company reported -€0.235 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.235.
Is Biotest (0N6Z) overvalued?
According to Wall Street analysts Biotest (0N6Z)’s price is currently Overvalued.
Does Biotest (0N6Z) pay dividends?
Biotest (0N6Z) pays a Notavailable dividend of €0.039 which represents an annual dividend yield of 0.1%. See more information on Biotest (0N6Z) dividends here
What is Biotest (0N6Z)’s EPS estimate?
Biotest (0N6Z)’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biotest (0N6Z) have?
Biotest (0N6Z) has 19,785,727 shares outstanding.
What happened to Biotest (0N6Z)’s price movement after its last earnings report?
Biotest (0N6Z) reported an EPS of -€0.235 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Biotest (0N6Z)?
Currently, no hedge funds are holding shares in DE:BIO
---
Biotest (0N6Z) Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
―
20 days / 200 days
Momentum
-2.31%
12-Months-Change
Fundamentals
Return on Equity
13.87%
Trailing 12-Months
Asset Growth
-0.21%
Trailing 12-Months
Company Description
Biotest (0N6Z)
Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.
---
Technical Analysis
Biotest
―
GlaxoSmithKline
―
AstraZeneca
―
Hikma Pharmaceuticals
―
Affimed
―
Mainz Biomed B.V.
―
---